Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01258
|
|||||
| Drug Name |
Chrysin
|
|||||
| Synonyms |
3CN01F5ZJ5; 480-40-0; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-phenyl-; 5,7-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one; 5,7-Dihydroxy-2-phenyl-4H-benzo(b)pyran-4-one; 5,7-Dihydroxy-2-phenyl-4H-chromen-4-one; 5,7-Dihydroxy-2-phenyl-chromen-4-one; 5,7-Dihydroxyflavone; 5,7-dihydroxy-2-phenylchromen-4-one; BRN 0233276; CAS-480-40-0; CHEBI:75095; CHEMBL117; Chrysin, 99+%; Chrysine; Crysin; EINECS 207-549-7; FLAVONE, 5,7-DIHYDROXY-; MFCD00006834; NSC 407436; NSC-407436; NSC407436; RTIXKCRFFJGDFG-UHFFFAOYSA-N; UNII-3CN01F5ZJ5; chrysin
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Dietary supplements [ICD11: 5B7Z] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H10O4
|
|||||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O
|
|||||
| InChI |
InChI=1S/C15H10O4/c16-10-6-11(17)15-12(18)8-13(19-14(15)7-10)9-4-2-1-3-5-9/h1-8,16-17H
|
|||||
| InChIKey |
RTIXKCRFFJGDFG-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 480-40-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 254.24 | Topological Polar Surface Area | 66.8 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
2.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:75095
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [1] | |
| References | ||||||
| 1 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.